MRI and ultrasound-guided prostate biopsy using soft image fusion

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3383-3390

  Rud, Erik ^a   Baco, Eduard ^a   Eggesbø, Heidi B ^a,b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

MRI; Prostate cancer; Soft image fusion; Targeted biopsy; TRUS

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; ULTRASONOGRAPHY;

EID: 84865701101     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hambrock, T, Somford, DM, Hoeks C, Bouwense SAW, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ and Barentsz JO: Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen. JURO 183: 520-528, 2010.
2. Cheikh AB, Girouin N, Colombel M, Maréchal JM, Gelet A, Bissery A, Rabilloud M, Lyonnet D and Rouvière O: Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 19: 770-778, 2008.
3. Park BK, Lee HM, Kim CK, Choi HY and Park JW: Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy. Invest Radiol 43: 789-793, 2008.
4. Ukimura O: Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer. Expert Rev Med Dev 7: 541-554, 2010.
5. Ukimura O, Faber K and Gill IS: Intraprostatic targeting. Curr Opini Urol 22: 97-103, 2012.
6. Hadaschik, BA, Kuru TH, Tulea C, Rieker P, Popeneciu IV, Simpfendörfer T, Huber J, Zogal P, Teber D, Pahernik S, Roethke M, Zamecnik P, Roth W, Sakas G, Schlemmer HP and Hohenfellner M: A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol 186: 2214-2220, 2011.
7. Pinto PA, Chung PH, Rastinehad AR, Baccala AA Jr., Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner, C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL and Wood BJ: Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance Imaging. JURO 186: 1281-1285, 2011.
8. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood B. J, Choyke PL and Pinto PA: Documenting the location of prostate biopsies with image fusion. BJU Int 107: 53-57, 2010.
9. Hu Y, Ahmed H, Taylor Z and Allen C: MR to ultrasound registration for image-guided prostate interventions. Med Image Anal 16: 687-703, 2012.
10. Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P and Wood BJ: Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 13: 255-264, 2008.
11. Yan P, Xu S, Turkbey B and Kruecker J: Discrete deformable model guided by partial active shape model for TRUS image segmentation. IEEE Trans Biomed Eng 57: 1158-1166, 2010.
12. Baumann M, Mozer P, Daanen V and Troccaz J: Prostate biopsy tracking with deformation estimation. Med Image Anal 16: 562-576, 2011.
13. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouvière, O, Logager V and Futterer JJ: ESUR prostate MR guidelines 2012. Eur Radiol 2012.
14. Delongchamps NB, Beuvon F, Eiss D, Flam T, Muradyan N, Zerbib M, Peyromaure M and Cornud F: Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer. Prostate Cancer Prostatic Dis 14: 232-237, 2011.
15. Coakley FV and Hricak H: Radiologic anatomy of the prostate gland: a clinical approach. Radiol Clin North Am 38: 15-30, 2000.
16. Verma S and Rajesh A: A Clinically Relevant Approach to Imaging Prostate Cancer: Review. Am J Roentgenol 196: S1-S10, 2011.
17. van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B and Group, T. I. P. C: International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24: 16-25, 2010.
18. Girouin N, Mège-Lechevallier F, Tonina Senes A, Bissery A, Rabilloud M, Maréchal JM, Colombel M, Lyonnet D and Rouvière O: Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17: 1498-1509, 2006.
19. Lemaitre L, Puech P, Poncelet E, Bouyé S, Leroy X, Biserte J and Villers A Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 19: 470-480, 2008.
20. Cornud F, Delongchamps NB, Mozer P, Beuvon F, Schull A, Muradyan N and Peyromaure, M. Value of Multiparametric MRI in the Work-up of Prostate Cancer. Curr Urol Rep 13: 82-92, 2011.
21. Epstein JI: An Update of the Gleason Grading System. JURO 183: 433-440, 2010.
22. Tan N, Lane BR, Li J, Moussa AS, Soriano M and Jones JS: Prostate Cancers Diagnosed at Repeat Biopsy are Smaller and Less Likely to be High Grade. J Urol 180: 1325-1329, 2008.
23. Iwazawa J, Mitani T, Sassa S and Ohue S: Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? Diagn Interv Radiol 17: 243-248, 2011.